A precision-medicine protocol for treating acromegaly can slash healthcare costs by 22% while more than doubling a patient’s chances of reaching hormonal remission, according to an economic analysis of the ACROFAST clinical trial. “Cost-effectiveness of personalized medical treatment in acromegaly: a post hoc analysis of the ACROFAST study,” a Spanish study recently published in the […]
ACROFAST Findings: Personalized Care for Acromegaly Wins on Both Health and Budget
Join the Global Movement Advancing Endocrine Science and Medicine
Become a part of a community of 18,000-plus endocrine investigators and clinicians who conduct research and provide quality patient care in more than 100 countries. Advance your career and the field of endocrinology through our many educational, leadership and advocacy opportunities.